Syndax Pharmaceuticals Inc
|Market Cap (Intraday)||1.04B|
|2yr Forward PE||N/A|
Syndax Pharmaceuticals, Inc. Stock, NASDAQ:SNDX
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.